Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Basal Cell 7 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 3 Keratosis, Actinic 3 Cholangiocarcinoma 3 Tongue Neoplasms 2 Pleural Diseases 2 Non-Muscle Invasive Bladder Neoplasms 2 Mycosis Fungoides 2 Mesothelioma, Malignant 2 Carcinoma, Transitional Cell 2 Bile Duct Neoplasms 2 Basal Cell Nevus Syndrome 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomatitis 1 Skin Neoplasms 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Photosensitivity Disorders 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1

Interventions

Low-Level Light Therapy 14 Fibroblast Growth Factor 7 10 Cisplatin 6 Standard of Care 5 avasopasem manganese 4 Radiotherapy, Intensity-Modulated 4 Propolis 4 Mouthwashes 4 Cryotherapy 4 Water 3 Sodium Bicarbonate 3 Saline Solution 3 Radiotherapy 3 Laser Therapy 3 Injections 3 Drug Therapy 3 Control Groups 3 Benzydamine 3 golotimod 2 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Vitamin E 2 Vitamin B 12 2 Sodium Chloride 2 Saliva, Artificial 2 RRx-001 2 Practice Guidelines as Topic 2 Lidocaine 2 Honey 2 Glutamine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomatitis × 1-phenyl-3,3-dimethyltriazene × Clear all

NCT02555501 2015-09-21

OMLTPT

Universidade Ceuma

Phase 3 Completed

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡